Use of linezolid in a high complexity hospital of Bogotá city

J. López G., Carlos Mauricio Calderón V., Y. Cortázar C
{"title":"Use of linezolid in a high complexity hospital of Bogotá city","authors":"J. López G., Carlos Mauricio Calderón V., Y. Cortázar C","doi":"10.15446/rcciquifa.v51n1.102726","DOIUrl":null,"url":null,"abstract":"Introduction: Studying the prescription of last generation antibiotics helps to identify the causes and consequences of the inadequate use of antibiotics. These include the appearance of antibacterial resistance, a situation declared by the WHO as a global public health problem. Aim: To describe the prescription of linezolid in a high complexity hospital in Bogotá, Colombia,considering the follow-up of the recommendations for the use of the drug included in clinical practice guidelines (CPG) and its indications. Methods: A descriptive observational study of longitudinal section was performed with retrospective collection of the information of all patients who were prescribed linezolid, at a minimum dose of 600 mg every 12 h during their hospitalization in the period from January 1st, 2017, to December 31st, 2018. The characteristics of linezolid prescription were described. Results: 133 prescriptions were reviewed. The most frequently diagnosed were sepsis of different origin (pulmonary abdominal, urinary) with 22.6 % (30/133), followed by skin and soft tissue infection 16.5 % (22/133), the pneumonia with 12.8 % (17/133) and urinary tract infections with 9.8 % (13/133). Two days treatment was the most frequent (range 1-30 days). In 33 % (44/133) of the patients, linezolid was used empirically (without using a previous antibiotic), while in 40.6 % (54/133) it was used as a second option (a previous antibiotic scheme). It was used as a third option in 20.3 % (27/133). Finally, in 6 % (8/133) of the patients, linezolid was prescribed after three previous antibiotics. It was necessary to use another antibiotic in near fifty percent of patients because linezolid did not work. Conclusions: The present study shows that there is little adherence to the institutional CPGs in relation to the treatment time, the microorganism identification, and the use as first option. The absence of a full-time infectious disease specialist, the high workload and the continuous rotation of prescribing staff may be the causeof these results. Some cases of inappropriate use may be related to the clinicalcondition of the patient which requires empirical treatments.","PeriodicalId":21220,"journal":{"name":"Revista Colombiana de Ciencias Químico-Farmacéuticas","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Colombiana de Ciencias Químico-Farmacéuticas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15446/rcciquifa.v51n1.102726","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Studying the prescription of last generation antibiotics helps to identify the causes and consequences of the inadequate use of antibiotics. These include the appearance of antibacterial resistance, a situation declared by the WHO as a global public health problem. Aim: To describe the prescription of linezolid in a high complexity hospital in Bogotá, Colombia,considering the follow-up of the recommendations for the use of the drug included in clinical practice guidelines (CPG) and its indications. Methods: A descriptive observational study of longitudinal section was performed with retrospective collection of the information of all patients who were prescribed linezolid, at a minimum dose of 600 mg every 12 h during their hospitalization in the period from January 1st, 2017, to December 31st, 2018. The characteristics of linezolid prescription were described. Results: 133 prescriptions were reviewed. The most frequently diagnosed were sepsis of different origin (pulmonary abdominal, urinary) with 22.6 % (30/133), followed by skin and soft tissue infection 16.5 % (22/133), the pneumonia with 12.8 % (17/133) and urinary tract infections with 9.8 % (13/133). Two days treatment was the most frequent (range 1-30 days). In 33 % (44/133) of the patients, linezolid was used empirically (without using a previous antibiotic), while in 40.6 % (54/133) it was used as a second option (a previous antibiotic scheme). It was used as a third option in 20.3 % (27/133). Finally, in 6 % (8/133) of the patients, linezolid was prescribed after three previous antibiotics. It was necessary to use another antibiotic in near fifty percent of patients because linezolid did not work. Conclusions: The present study shows that there is little adherence to the institutional CPGs in relation to the treatment time, the microorganism identification, and the use as first option. The absence of a full-time infectious disease specialist, the high workload and the continuous rotation of prescribing staff may be the causeof these results. Some cases of inappropriate use may be related to the clinicalcondition of the patient which requires empirical treatments.
波哥哥市一家高复杂性医院利奈唑胺的使用
前言:研究上一代抗生素的处方有助于确定抗生素使用不当的原因和后果。其中包括抗菌药物耐药性的出现,这是世界卫生组织宣布的全球公共卫生问题。目的:描述哥伦比亚波哥大一家高复杂性医院的利奈唑胺处方,考虑到临床实践指南(CPG)中关于使用该药物的建议及其适应症的后续行动。方法:回顾性收集2017年1月1日至2018年12月31日住院期间使用利奈唑胺最低剂量600mg / 12h的患者资料,采用纵剖面描述性观察研究。介绍了利奈唑胺处方的特点。结果:共审查处方133张。诊断最多的是不同来源的脓毒症(肺、腹、尿),占22.6%(30/133),其次是皮肤和软组织感染16.5%(22/133),肺炎12.8%(17/133),尿路感染9.8%(13/133)。2天的治疗是最常见的(1-30天)。在33%(44/133)的患者中,利奈唑胺是经验性使用的(没有使用过以前的抗生素),而在40.6%(54/133)的患者中,利奈唑胺是第二选择(以前的抗生素方案)。20.3%(27/133)的患者将其作为第三种选择。最后,在6%(8/133)的患者中,利奈唑胺是在之前使用过三种抗生素后才开的。近50%的患者需要使用另一种抗生素,因为利奈唑胺不起作用。结论:目前的研究表明,在治疗时间、微生物鉴定和首选使用方面,机构CPGs的依从性较低。造成这些结果的原因可能是缺乏专职传染病专家、工作量大以及处方人员不断轮换。一些使用不当的病例可能与患者的临床状况有关,需要经验性治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信